{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:16:10Z","timestamp":1790716570436,"version":"4.1.0"},"reference-count":77,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","license":[{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,5,19]]},"abstract":"<jats:p>Acute lymphoblastic leukemia (ALL) is a common cancer affecting children worldwide. The development of ALL is driven by several genes, some of which can be targeted for treatment by inhibiting gene fusions. PAX5 is frequently mutated in ALL and is involved in chromosomal rearrangements and translocations. Mutations in PAX5 interact with other genes, such as ETV6 and FOXP1, which influence B-cell development. PAX5\/ETV6 has been observed in both B-ALL patients and a mouse model. The interaction between PAX5 and FOXP1 negatively suppresses the Pax5 gene in B-ALL patients.<\/jats:p>\n          <jats:p>Additionally, ELN and PML genes have been found to fuse with PAX5, leading to adverse effects on B-cell differentiation. ELN-PAX5 interaction results in the decreased expression of LEF1, MB1, and BLNK, while PML-PAX5 is critical in the early stages of leukemia. PAX5 fusion genes prevent the transcription of the PAX5 gene, making it an essential target gene for the study of leukemia progression and the diagnosis of B-ALL.<\/jats:p>","DOI":"10.1097\/md.0000000000033836","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:03:52Z","timestamp":1684451032000},"page":"e33836","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["PAX5 fusion genes in acute lymphoblastic leukemia: A literature review"],"prefix":"10.1097","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7440-3820","authenticated-orcid":false,"given":"Fatma Mohamed","family":"Fouad","sequence":"first","affiliation":[{"name":"Biology Department, College of Science, Sultan Qaboos University, Muscat, Oman"},{"name":"Chemistry Department, Biotechnology\/Bimolecular Chemistry program, Faculty of Science, Cairo University, Giza, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jehane I.","family":"Eid","sequence":"additional","affiliation":[{"name":"Zoology Department, Faculty of Science, Cairo University, Giza, Egypt."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"942053","DOI":"10.3389\/fcell.2022.942053","article-title":"JAK2 alterations in acute lymphoblastic leukemia: molecular insights for superior precision medicine strategies.","volume":"10","author":"Downes","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/BS9.0000000000000078","article-title":"Colony-stimulating factor 3 receptor (CSF3R) M696T mutation does not impact on clinical outcomes of a Ph+ acute lymphoblastic leukemia patient.","volume":"3","author":"Chen","year":"2021","journal-title":"Blood Sci"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s10552-015-0618-0","article-title":"Home paint exposures and risk of childhood acute lymphoblastic leukemia: findings from the childhood leukemia international consortium.","volume":"26","author":"Bailey","year":"2015","journal-title":"Cancer Causes Control"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41598-022-23682-z","article-title":"Outdoor artificial light at night, air pollution, and risk of childhood acute lymphoblastic leukemia in the California Linkage Study of Early-Onset Cancers.","volume":"13","author":"Zhong","year":"2023","journal-title":"Sci Rep"},{"key":"R7-20250504","article-title":"Suspicions regarding the genetic inheritance of acute lymphoblastic leukemia in patients with down syndrome.","author":"Behluli","year":"2022","journal-title":"J Mother Child"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"9753","DOI":"10.3390\/curroncol29120766","article-title":"Acute lymphoblastic leukemia developing in a patient with 46, XY pure gonadal dysgenesis (Swyer syndrome) with malignant gonadal germ cell tumor: a case report and literature review.","volume":"29","author":"Zhang","year":"2022","journal-title":"Curr Oncol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"e29873","DOI":"10.1002\/pbc.29873","article-title":"Precursor B-cell acute lymphoblastic leukemia in a pediatric patient with Bainbridge-Ropers syndrome.","volume":"70","author":"Slatnick","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"R10-20250504","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2022.281583","article-title":"TAL1 activation in T-Cell acute lymphoblastic leukemia: a novel oncogenic 3\u2032 neoenhancer.","author":"Smith","year":"2023","journal-title":"Haematologica"},{"key":"R11-20250504","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2022-158556","article-title":"Identification of TCF3 germline variants in pediatric B-cell acute lymphoblastic leukemia.","author":"Escherich","year":"2022","journal-title":"Blood Adv"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12920-022-01325-6","article-title":"Association of IKZF1 and CDKN2A gene polymorphisms with childhood acute lymphoblastic leukemia: a high-resolution melting analysis.","volume":"15","author":"Sattarzadeh Bardsiri","year":"2022","journal-title":"BMC Med Genomics"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"e7195","DOI":"10.7717\/peerj.7195","article-title":"Risk assessment of FLT3 and PAX5 variants in B-acute lymphoblastic leukemia: a case-control study in a Pakistani cohort.","volume":"7","author":"Khalid","year":"2019","journal-title":"PeerJ"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1182\/blood.2020006164","article-title":"Molecular basis of ETV6-mediated predisposition to childhood acute lymphoblastic leukemia.","volume":"137","author":"Nishii","year":"2021","journal-title":"Blood"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"e376","DOI":"10.1016\/j.clml.2021.12.006","article-title":"Prognostic significance of CRLF2 overexpression and JAK2 mutation in egyptian pediatric patients with B-precursor acute lymphoblastic leukemia.","volume":"22","author":"Hassan","year":"2022","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"R16-20250504","first-page":"19","article-title":"[Mutational spectrum and its prognostic significance in childhood acute lymphoblastic leukemia based on next-generation sequencing technology].","volume":"43","author":"Zheng","year":"2022","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1158\/1055-9965.EPI-18-0801","article-title":"Is there etiologic heterogeneity between subtypes of childhood acute lymphoblastic leukemia? A review of variation in risk by subtype.","volume":"28","author":"Williams","year":"2019","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00428-022-03448-8","article-title":"International consensus classification of acute lymphoblastic leukemia\/lymphoma.","volume":"482","author":"Duffield","year":"2023","journal-title":"Virchows Arch"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.exphem.2015.05.015","article-title":"Molecular basis and clinical significance of genetic aberrations in B-cell precursor acute lymphoblastic leukemia.","volume":"43","author":"Ghazavi","year":"2015","journal-title":"Exp Hematol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11684-020-0821-6","article-title":"Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia.","volume":"15","author":"Li","year":"2021","journal-title":"Front Med"},{"key":"R22-20250504","first-page":"161","article-title":"A typical bedside-to-bench investigation of leukemogenic driver MEF2D fusion reveals new targeted therapy in B-cell acute lymphoblastic leukemia.","volume":"4","author":"Zhang","year":"2022","journal-title":"Blood Sci"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.18632\/oncotarget.23380","article-title":"Identification of survivin as a promising target for the immunotherapy of adult B-cell acute lymphoblastic leukemia.","volume":"9","author":"Boullosa","year":"2018","journal-title":"Oncotarget"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s11033-020-06072-4","article-title":"Evaluation of the clinical significance of RNase III enzyme DROSHA in pediatrics acute lymphocytic leukemia.","volume":"48","author":"Hajirostamlou","year":"2021","journal-title":"Mol Biol Rep"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/hon.2818","article-title":"Clinical trial risk in leukemia: biomarkers and trial design.","volume":"39","author":"Li","year":"2021","journal-title":"Hematol Oncol"},{"key":"R26-20250504","first-page":"1700","article-title":"[The Application of RNA-sequencing in pediatric B-Cell acute lymphoblastic leukemia].","volume":"30","author":"Zou","year":"2022","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"pkac029","DOI":"10.1093\/jncics\/pkac029","article-title":"Long-term risk of hospitalization for somatic diseases among survivors of childhood acute lymphoblastic leukemia.","volume":"6","author":"S\u00f8rensen","year":"2022","journal-title":"JNCI Cancer Spectr"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.3390\/jcm11216298","article-title":"Spectrum of genetic mutations in Korean pediatric acute lymphoblastic leukemia.","volume":"11","author":"Yoo","year":"2022","journal-title":"J Clin Med"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1182\/bloodadvances.2021004895","article-title":"Distinct clinical characteristics of DUX4- and PAX5-altered childhood B-lymphoblastic leukemia.","volume":"5","author":"Li","year":"2021","journal-title":"Blood Adv"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41568-020-00315-z","article-title":"Advances in germline predisposition to acute leukaemias and myeloid neoplasms.","volume":"21","author":"Klco","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/B978-0-12-385991-4.00005-2","article-title":"Pax5: a master regulator of B cell development and leukemogenesis.","volume":"111","author":"Medvedovic","year":"2011","journal-title":"Adv Immunol"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1182\/blood-2009-07-234229","article-title":"Diversity of PAX5 alterations in B-ALL: a groupe francophone de cytogenetique hematologique study.","volume":"115","author":"Coyaud","year":"2010","journal-title":"Blood"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1038\/leu.2009.135","article-title":"PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study.","volume":"23","author":"Familiades","year":"2009","journal-title":"Leukemia"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature05690","article-title":"Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia.","volume":"446","author":"Mullighan","year":"2007","journal-title":"Nature"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/leu.2008.306","article-title":"Incidence and diversity of PAX5 fusion genes in childhood acute lymphoblastic leukemia.","volume":"23","author":"Nebral","year":"2009","journal-title":"Leukemia"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1038\/leu.2013.92","article-title":"Impact of IKZF1 deletions and PAX5 amplifications in pediatric B-cell precursor ALL treated according to NOPHO protocols.","volume":"27","author":"Ofverholm","year":"2013","journal-title":"Leukemia"},{"key":"R37-20250504","first-page":"527","article-title":"Evolution and function of Pax genes \u201cencyclopedia of the human Genome.","volume":"4","author":"Bouchard","year":"2003","journal-title":"Encycl Human Genome"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/bies.950190905","article-title":"Pax genes and organogenesis.","volume":"19","author":"Dahl","year":"1997","journal-title":"BioEssays News Rev Mol Cell Dev Biol"},{"issue":"7 Suppl","key":"R39-20250504","first-page":"1707s","article-title":"Pax genes and their role in organogenesis.","volume":"59","author":"Mansouri","year":"1999","journal-title":"Cancer Res"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/0888-7543(91)90151-4","article-title":"Pax: a murine multigene family of paired box-containing genes.","volume":"11","author":"Walther","year":"1991","journal-title":"Genomics"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/ng0493-292","article-title":"Chromosomal localization of seven PAX genes and cloning of a novel family member, PAX-9.","volume":"3","author":"Stapleton","year":"1993","journal-title":"Nat Genet"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1093\/emboj\/17.8.2319","article-title":"Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments.","volume":"17","author":"Nutt","year":"1998","journal-title":"EMBO J"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1182\/blood-2006-05-025221","article-title":"A novel PAX5-ELN fusion protein identified in B-cell acute lymphoblastic leukemia acts as a dominant negative on wild-type PAX5.","volume":"109","author":"Bousquet","year":"2007","journal-title":"Blood"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.3390\/ijms23052755","article-title":"Genetic biomarkers and their clinical implications in B-Cell acute lymphoblastic leukemia in children.","volume":"23","author":"Lejman","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0140-6736(19)33018-1","article-title":"Acute lymphoblastic leukaemia.","volume":"395","author":"Malard","year":"2020","journal-title":"Lancet Lond Engl"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/JLB.5A0721-361R","article-title":"Genomic heterogeneity contributed to different prognosis between adult and pediatric acute lymphoblastic.","volume":"112","author":"Chen","year":"2022","journal-title":"J Leukoc Biol"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/gcc.20214","article-title":"PAX5\/IGH rearrangement is a recurrent finding in a subset of aggressive B-NHL with complex chromosomal rearrangements.","volume":"44","author":"Poppe","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1182\/blood.2020009564","article-title":"EBF1 and PAX5 control pro-B cell expansion via opposing regulation of the Myc gene.","volume":"137","author":"Somasundaram","year":"2021","journal-title":"Blood"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/leu.2012.281","article-title":"PAX5\/ETV6 alters the gene expression profile of precursor B cells with opposite dominant effect on endogenous PAX5.","volume":"27","author":"Fazio","year":"2013","journal-title":"Leukemia"},{"key":"R50-20250504","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/onc.2010.473","article-title":"The reduced and altered activities of PAX5 are linked to the protein-protein interaction motif (coiled-coil domain) of the PAX5-PML fusion protein in t(9;15)-associated acute lymphocytic leukemia.","volume":"30","author":"Qiu","year":"2011","journal-title":"Oncogene"},{"key":"R51-20250504","doi-asserted-by":"crossref","first-page":"104725","DOI":"10.1016\/j.ejmg.2023.104725","article-title":"Functional damaging germline variants in ETV6, IKZF1, PAX5 and RUNX1 predisposing to B-cell precursor acute lymphoblastic leukemia.","volume":"66","author":"Wagener","year":"2023","journal-title":"Eur J Med Genet"},{"key":"R52-20250504","doi-asserted-by":"crossref","first-page":"e108397","DOI":"10.15252\/embj.2021108397","article-title":"The PAX5-JAK2 translocation acts as dual-hit mutation that promotes aggressive B-cell leukemia via nuclear STAT5 activation.","volume":"41","author":"Jurado","year":"2022","journal-title":"EMBO J"},{"key":"R53-20250504","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/s00277-018-3291-z","article-title":"A patient with B-cell acute lymphoblastic leukemia with PAX5-ETV6 rearrangement with dic(9;12)(p13;p13) identified by chromosomal microarray.","volume":"97","author":"Ha","year":"2018","journal-title":"Ann Hematol"},{"key":"R54-20250504","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/dvg.22963","article-title":"Transcriptional regulation of the proto-oncogene Zfp521 by SPI1 (PU.1) and HOXC13.","volume":"54","author":"Yu","year":"2016","journal-title":"Genesis"},{"key":"R55-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2023.03.002","article-title":"Clinicopathologic characteristics, genetic features, and treatment options for acute lymphoblastic leukemia with JAK2 rearrangement-A 10-case study and literature review.","volume":"136","author":"Zhang","year":"2023","journal-title":"Hum Pathol"},{"key":"R56-20250504","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1097\/HS9.0000000000000053","article-title":"Advances in B-cell precursor acute lymphoblastic leukemia genomics.","volume":"2","author":"Schwab","year":"2018","journal-title":"Hemasphere"},{"key":"R57-20250504","doi-asserted-by":"crossref","first-page":"718","DOI":"10.15252\/embj.201695495","article-title":"Molecular role of the PAX5-ETV6 oncoprotein in promoting B-cell acute lymphoblastic leukemia.","volume":"36","author":"Smeenk","year":"2017","journal-title":"EMBO J"},{"key":"R58-20250504","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1038\/s41388-018-0573-9","article-title":"Chromosomal translocation-mediated evasion from miRNA induces strong MEF2D fusion protein expression, causing inhibition of PAX5 transcriptional activity.","volume":"38","author":"Hirano","year":"2019","journal-title":"Oncogene"},{"key":"R59-20250504","doi-asserted-by":"crossref","first-page":"104224","DOI":"10.1016\/j.ebiom.2022.104224","article-title":"PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120.","volume":"83","author":"Fazio","year":"2022","journal-title":"EBioMedicine"},{"key":"R60-20250504","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s12185-020-02944-4","article-title":"Functional analysis of a novel fusion protein PAX5-KIDINS220 identified in a pediatric Ph-like ALL patient.","volume":"112","author":"Kanayama","year":"2020","journal-title":"Int J Hematol"},{"key":"R61-20250504","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1182\/asheducation-2018.1.137","article-title":"Genetics and prognosis of ALL in children vs adults.","volume":"2018","author":"Roberts","year":"2018","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"R62-20250504","doi-asserted-by":"crossref","first-page":"17050","DOI":"10.1073\/pnas.0803494105","article-title":"Variable breakpoints target PAX5 in patients with dicentric chromosomes: a model for the basis of unbalanced translocations in cancer.","volume":"105","author":"An","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"R63-20250504","first-page":"4666","article-title":"The paired box domain gene PAX5 is fused to ETV6\/TEL in an acute lymphoblastic leukemia case.","volume":"61","author":"Cazzaniga","year":"2001","journal-title":"Cancer Res"},{"key":"R64-20250504","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.semcancer.2005.01.008","article-title":"ETV6: a versatile player in leukemogenesis.","volume":"15","author":"Bohlander","year":"2005","journal-title":"Semin Cancer Biol"},{"key":"R65-20250504","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/sj.leu.2402923","article-title":"PAX5\/ETV6 fusion defines cytogenetic entity dic(9;12)(p13;p13).","volume":"17","author":"Strehl","year":"2003","journal-title":"Leukemia"},{"key":"R67-20250504","doi-asserted-by":"crossref","first-page":"11921","DOI":"10.1073\/pnas.0711039105","article-title":"Cloning of genes involved in chromosomal translocations by high-resolution single nucleotide polymorphism genomic microarray.","volume":"105","author":"Kawamata","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"R68-20250504","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1158\/1541-7786.MCR-13-0337","article-title":"Functional heterogeneity of PAX5 chimeras reveals insight for leukemia development.","volume":"12","author":"Fortschegger","year":"2014","journal-title":"Mol Cancer Res"},{"key":"R69-20250504","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/onc.2010.554","article-title":"PAX5-PML acts as a dual dominant-negative form of both PAX5 and PML.","volume":"30","author":"Kurahashi","year":"2011","journal-title":"Oncogene"},{"key":"R70-20250504","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1158\/0008-5472.CAN-07-2778","article-title":"PAX5\/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells.","volume":"68","author":"Fazio","year":"2008","journal-title":"Cancer Res"},{"key":"R71-20250504","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.18632\/oncotarget.2807","article-title":"LCK over-expression drives STAT5 oncogenic signaling in PAX5 translocated BCP-ALL patients.","volume":"6","author":"Cazzaniga","year":"2015","journal-title":"Oncotarget"},{"key":"R72-20250504","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/246461a0","article-title":"Molecular model for elastin structure and function.","volume":"246","author":"Gray","year":"1973","journal-title":"Nature"},{"key":"R73-20250504","doi-asserted-by":"crossref","first-page":"10357","DOI":"10.1073\/pnas.1721678115","article-title":"PAX5-ELN oncoprotein promotes multistep B-cell acute lymphoblastic leukemia in mice.","volume":"115","author":"Jamrog","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"R74-20250504","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1101\/gad.14.2.142","article-title":"Unified nomenclature for the winged helix\/forkhead transcription factors.","volume":"14","author":"Kaestner","year":"2000","journal-title":"Genes Dev"},{"key":"R75-20250504","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/nri1488","article-title":"Forkhead-box transcription factors and their role in the immune system.","volume":"4","author":"Coffer","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"R76-20250504","first-page":"1495","article-title":"Human FOX gene family (Review).","volume":"25","author":"Katoh","year":"2004","journal-title":"Int J Oncol"},{"key":"R77-20250504","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/ni1358","article-title":"Foxp1 is an essential transcriptional regulator of B cell development.","volume":"7","author":"Hu","year":"2006","journal-title":"Nat Immunol"},{"key":"R78-20250504","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/nri953","article-title":"Lymphoid malignancies: the dark side of B-cell differentiation.","volume":"2","author":"Shaffer","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"R79-20250504","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cancergen.2011.07.006","article-title":"FOXP1 and PAX5 are rare but recurrent translocations partners in acute lymphoblastic leukemia.","volume":"204","author":"Put","year":"2011","journal-title":"Cancer Genet"},{"key":"R80-20250504","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2141.2007.06731.x","article-title":"Identification of PML as novel PAX5 fusion partner in childhood acute lymphoblastic leukaemia.","volume":"139","author":"Nebral","year":"2007","journal-title":"Br J Haematol"},{"key":"R81-20250504","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1084\/jem.191.4.631","article-title":"Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis.","volume":"191","author":"Zhong","year":"2000","journal-title":"J Exp Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033836","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:03:55Z","timestamp":1746324235000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,19]]},"references-count":77,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000033836","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,19]]}}}